4//SEC Filing
Roberts Michael J 4
Accession 0001181431-10-041578
CIK 0001333763other
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 2:05 PM ET
Size
14.2 KB
Accession
0001181431-10-041578
Insider Transaction Report
Form 4
Roberts Michael J
VP, Business Development
Transactions
- Purchase
Common Stock
2010-08-11$3.10/sh+2,000$6,200→ 22,000 total
Holdings
- 35,000
Stock Option (Right to Buy)
Exercise: $1.50Exp: 2019-02-09→ Common Stock (35,000 underlying) - 35,000
Stock Option (Right to Buy)
Exercise: $5.68Exp: 2017-02-06→ Common Stock (35,000 underlying) - 35,000
Stock Option (Right to Buy)
Exercise: $3.50Exp: 2016-02-01→ Common Stock (35,000 underlying) - 48,247
Stock Option (Right to Buy)
Exercise: $2.62Exp: 2015-01-10→ Common Stock (48,247 underlying) - 21,078
Stock Option (Right to Buy)
Exercise: $0.18Exp: 2014-08-23→ Common Stock (21,078 underlying) - 50,000
Stock Option (Right to Buy)
Exercise: $2.96Exp: 2020-01-19→ Common Stock (50,000 underlying) - 35,000
Stock Option (Right to Buy)
Exercise: $6.34Exp: 2018-01-29→ Common Stock (35,000 underlying)
Footnotes (7)
- [F1]Option vests in four equal annual installments beginning on January 19, 2011.
- [F2]Option vests in four equal annual installments beginning on February 9, 2010.
- [F3]Option vests in four equal annual installments beginning on January 29, 2009.
- [F4]Option vests in four equal annual installments beginning on February 6, 2008.
- [F5]Option vests in four equal annual installments beginning on February 1, 2007.
- [F6]Option vested in four equal annual installments beginning on January 10, 2006.
- [F7]Option vested in two equal annual installments beginning on August 23, 2005.
Documents
Issuer
Chelsea Therapeutics International, Ltd.
CIK 0001333763
Entity typeother
Related Parties
1- filerCIK 0001481629
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 2:05 PM ET
- Size
- 14.2 KB